Pharmaceutical Executive
May 22, 2018
Features
38
5
In its 12th annual feature, Pharm Exec builds on the revamped approach it introduced last year in spotlighting notable biopharma brands, profiling a new round of products that are making waves in five key areas in healthcare and R&D.
May 16, 2018
Columns
38
5
Pair of EU meetings, while well-meant, offered little action and beg the question-what’s the true merit in working together?
May 09, 2018
Columns
38
5
Pharm Exec interviews the FDA commissioner, who is building support by combating opioid abuse and advancing innovation.
May 09, 2018
Features
38
5
Meeting the stringent cloud compliance and regulatory requirements in pharma.
May 08, 2018
From the Editor
38
5
Amid new efforts to inspire more physicians to engage their patients about clinical research, turning that vision into tangible gains in trial participation remains tricky.
May 08, 2018
Features
38
5
A former biology major, biotech investment banker, and venture capitalist, Tim Sullivan brings that sought-after melding of business and scientific perspectives to his role as chief financial officer for Apellis, a clinical-stage drug company hopeful of ushering in novel protein inhibitors form autoimmune disease.
May 08, 2018
Features
38
5
With digitalization enabling patient engagement with their own health experience more than ever before, two critical elements will steer pharma’s advertising path.
May 08, 2018
Features
38
5
Overcoming the challenges of digital brand management will involve choices in spending and channels.
May 07, 2018
Features
38
5
How “patient influencers” look beyond price to help the industry evaluate newly-launched brands.
May 05, 2018
Columns
38
5
Charting the course that has led to payer vertical integration and what it may mean for pharma manufacturers.
May 01, 2018
Columns
38
5
It’s just as hard to make treatments look good to physicians as it is patients-but communicating through entertainment can be done.
May 01, 2018
Special Sponsored Section
38
5
Away from the glare of publicity, a tranche of bold reforms in Canada, aimed at harmonizing the national health system and delivering value for money, are fast nearing completion.
May 01, 2018
Issue PDF
38
5
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.